Cocrystal Pharma (COCP) Revenue (2010 - 2026)

Cocrystal Pharma (COCP) reported Revenue of $225000.0 for Q1 2026, down 55.88% sequentially from $510000.0 in Q4 2020.

Cocrystal Pharma (COCP) Revenue (2010 - 2026) Analysis & Trends

Cocrystal Pharma (COCP) has 8 years of Revenue data on file, last reported at $225000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Revenue changed N/A year-over-year to $225000.0; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (changed N/A YoY), and the FY2020 full-year result was $2.0 million, down 69.32% from the prior year.
  • Revenue declined to $225000.0 in Q1 2026, from $510000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $225000.0 in Q1 2026 to a low of $225000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.51 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 2.99 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 3.61 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.56 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Cocrystal Pharma 12.57 Mn 7.74 Mn - 225,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 225,000.00
Dec 31, 2020 510,000.00
Sep 30, 2020 489,000.00
Jun 30, 2020 554,000.00
Mar 31, 2020 461,000.00
Dec 31, 2019 402,000.00
Sep 30, 2019 492,000.00
Jun 30, 2019 592,000.00
Mar 31, 2019 5.08 Mn
Sep 30, 2015 24,000.00
Jun 30, 2015 27,000.00
Mar 31, 2015 27,000.00
Jun 30, 2013 1.96 Mn
Mar 31, 2013 2.03 Mn
Dec 31, 2012 3.87 Mn
Sep 30, 2012 4.89 Mn
Jun 30, 2012 4.91 Mn
Mar 31, 2012 3.51 Mn
Dec 31, 2011 3.67 Mn
Sep 30, 2011 3.93 Mn